Abstract
An outbreak of digoxin intoxication brought about by an unannounced change affecting bioavailability by a manufacturer is reported. Public health implications are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 643-646 |
| Number of pages | 4 |
| Journal | Clinical Pharmacology and Therapeutics |
| Volume | 21 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1 Jan 1977 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)